• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冯·希佩尔-林道病、散发性小脑血管瘤病和肾细胞癌中两阶段突变模型的统计分析。

Statistical analysis of the two stage mutation model in von Hippel-Lindau disease, and in sporadic cerebellar haemangioblastoma and renal cell carcinoma.

作者信息

Maher E R, Yates J R, Ferguson-Smith M A

机构信息

Cambridge University Department of Pathology.

出版信息

J Med Genet. 1990 May;27(5):311-4. doi: 10.1136/jmg.27.5.311.

DOI:10.1136/jmg.27.5.311
PMID:2352258
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1017082/
Abstract

Analysis of the age incidence curves for unilateral and bilateral retinoblastoma led Knudson to propose that hereditary tumours may arise by a single event and sporadic tumours by a two stage mutation process. It has been suggested recently that sporadic renal cell carcinoma may arise from a two stage mutation process. We analysed the age incidence curves for symptomatic renal cell carcinoma (n = 26) and cerebellar haemangioblastoma (n = 68) in 109 patients with von Hippel-Lindau (VHL) disease, and compared them to 104 patients with sporadic renal cell carcinoma and 43 patients with sporadic cerebellar haemangioblastoma. The age incidence curves for renal cell carcinoma and cerebellar haemangioblastoma in VHL disease were compatible with a single mutation model, whereas the age incidence curves for sporadic renal cell carcinoma and cerebellar haemangioblastoma suggested a two stage mutation process. These data are compatible with the VHL gene functioning as a recessive tumour suppressor gene. Sporadic cerebellar haemangioblastoma and some renal cell carcinoma may arise from somatic mutations inactivating both alleles at the VHL locus.

摘要

对单侧和双侧视网膜母细胞瘤的年龄发病率曲线分析使克努森提出,遗传性肿瘤可能由单个事件引发,而散发性肿瘤则通过两阶段突变过程产生。最近有人提出,散发性肾细胞癌可能源于两阶段突变过程。我们分析了109例冯·希佩尔-林道(VHL)病患者中症状性肾细胞癌(n = 26)和小脑成血管细胞瘤(n = 68)的年龄发病率曲线,并将其与104例散发性肾细胞癌患者和43例散发性小脑成血管细胞瘤患者进行比较。VHL病中肾细胞癌和小脑成血管细胞瘤的年龄发病率曲线与单突变模型相符,而散发性肾细胞癌和小脑成血管细胞瘤的年龄发病率曲线提示两阶段突变过程。这些数据与VHL基因作为隐性肿瘤抑制基因发挥作用相符。散发性小脑成血管细胞瘤和一些肾细胞癌可能源于VHL基因座上两个等位基因均失活的体细胞突变。

相似文献

1
Statistical analysis of the two stage mutation model in von Hippel-Lindau disease, and in sporadic cerebellar haemangioblastoma and renal cell carcinoma.冯·希佩尔-林道病、散发性小脑血管瘤病和肾细胞癌中两阶段突变模型的统计分析。
J Med Genet. 1990 May;27(5):311-4. doi: 10.1136/jmg.27.5.311.
2
A genetic register for von Hippel-Lindau disease.冯·希佩尔-林道病的基因登记册。
J Med Genet. 1996 Feb;33(2):120-7. doi: 10.1136/jmg.33.2.120.
3
Investigation and Management of Apparently Sporadic Central Nervous System Haemangioblastoma for Evidence of Von Hippel-Lindau Disease.疑似散发性中枢神经系统血管母细胞瘤的调查与管理,以寻找 von Hippel-Lindau 病的证据。
Genes (Basel). 2021 Sep 15;12(9):1414. doi: 10.3390/genes12091414.
4
Specific genetic change in tumors associated with von Hippel-Lindau disease.与冯·希佩尔-林道病相关的肿瘤中的特定基因变化。
J Natl Cancer Inst. 1989 Jul 19;81(14):1097-101. doi: 10.1093/jnci/81.14.1097.
5
The impact of molecular genetic analysis of the VHL gene in patients with haemangioblastomas of the central nervous system.VHL基因分子遗传学分析对中枢神经系统血管母细胞瘤患者的影响。
J Neurol Neurosurg Psychiatry. 1999 Dec;67(6):758-62. doi: 10.1136/jnnp.67.6.758.
6
Prevalence, morphology and biology of renal cell carcinoma in von Hippel-Lindau disease compared to sporadic renal cell carcinoma.与散发性肾细胞癌相比,冯·希佩尔-林道病中肾细胞癌的患病率、形态学和生物学特征
J Urol. 1998 Oct;160(4):1248-54.
7
Clinical and molecular characterization of Brazilian families with von Hippel-Lindau disease: a need for delineating genotype-phenotype correlation.巴西血管母细胞瘤病家系的临床和分子特征:需要阐明基因型-表型相关性。
Fam Cancer. 2010 Dec;9(4):635-42. doi: 10.1007/s10689-010-9357-2.
8
[Von Hippel-Lindau disease: recent genetic progress and patient management. Francophone Study Group of von Hippel-Lindau Disease (GEFVH)].[冯·希佩尔-林道病:近期遗传学进展与患者管理。冯·希佩尔-林道病法语研究组(GEFVH)]
Ann Endocrinol (Paris). 1998;59(6):452-8.
9
Reconsideration of biallelic inactivation of the VHL tumour suppressor gene in hemangioblastomas of the central nervous system.对中枢神经系统血管母细胞瘤中VHL肿瘤抑制基因双等位基因失活的重新考量。
J Neurol Neurosurg Psychiatry. 2001 May;70(5):644-8. doi: 10.1136/jnnp.70.5.644.
10
Von Hippel-Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma.冯·希佩尔-林道病定位于与肾细胞癌相关的3号染色体区域。
Nature. 1988 Mar 17;332(6161):268-9. doi: 10.1038/332268a0.

引用本文的文献

1
Keratoconus: The Local Manifestation of a Systemic Disease?圆锥角膜:一种全身性疾病的局部表现?
J Clin Med. 2025 Jun 28;14(13):4587. doi: 10.3390/jcm14134587.
2
Stereotactic radiosurgery in the management of central nervous system hemangioblastomas: a systematic review and meta-analysis.立体定向放射外科治疗中枢神经系统血管母细胞瘤的系统评价与Meta分析
Neurosurg Rev. 2025 Mar 17;48(1):303. doi: 10.1007/s10143-025-03454-9.
3
Phenotypic and Genotypic Features of a Chinese Cohort with Retinal Hemangioblastoma.中国人视网膜血管母细胞瘤表型和基因型特征的研究。
Genes (Basel). 2024 Sep 11;15(9):1192. doi: 10.3390/genes15091192.
4
Oncogenic Cell Tagging and Single-Cell Transcriptomics Reveal Cell Type-Specific and Time-Resolved Responses to Vhl Inactivation in the Kidney.致癌细胞标记和单细胞转录组学揭示了 Vhl 失活在肾脏中的细胞类型特异性和时程反应。
Cancer Res. 2024 Jun 4;84(11):1799-1816. doi: 10.1158/0008-5472.CAN-23-3248.
5
Tumor heterogeneity in VHL drives metastasis in clear cell renal cell carcinoma.VHL 中的肿瘤异质性驱动透明细胞肾细胞癌的转移。
Signal Transduct Target Ther. 2023 Apr 17;8(1):155. doi: 10.1038/s41392-023-01362-2.
6
Bimodal Age Distribution in Cancer Incidence.癌症发病率的双峰年龄分布。
World J Oncol. 2022 Dec;13(6):329-336. doi: 10.14740/wjon1424. Epub 2022 Dec 24.
7
The Clinical and Molecular Features in the VHL Renal Cancers; Close or Distant Relatives with Sporadic Clear Cell Renal Cell Carcinoma?VHL 肾癌的临床和分子特征;与散发性透明细胞肾细胞癌是近亲还是远亲?
Cancers (Basel). 2022 Oct 30;14(21):5352. doi: 10.3390/cancers14215352.
8
Investigation and Management of Apparently Sporadic Central Nervous System Haemangioblastoma for Evidence of Von Hippel-Lindau Disease.疑似散发性中枢神经系统血管母细胞瘤的调查与管理,以寻找 von Hippel-Lindau 病的证据。
Genes (Basel). 2021 Sep 15;12(9):1414. doi: 10.3390/genes12091414.
9
Characterization of renal cell carcinoma-associated constitutional chromosome abnormalities by genome sequencing.通过基因组测序对肾癌相关的染色体结构异常进行特征分析。
Genes Chromosomes Cancer. 2020 Jun;59(6):333-347. doi: 10.1002/gcc.22833. Epub 2020 Feb 5.
10
The incidence of consecutive manifestations in Von Hippel-Lindau disease.von Hippel-Lindau 病的连续表现发生率。
Fam Cancer. 2019 Jul;18(3):369-376. doi: 10.1007/s10689-019-00131-x.

本文引用的文献

1
LINDAU'S DISEASE. REVIEW OF THE LITERATURE AND STUDY OF A LARGE KINDRED.林道氏病。文献综述及一个大家系的研究
Am J Med. 1964 Apr;36:595-617. doi: 10.1016/0002-9343(64)90107-x.
2
Familial renal carcinoma.家族性肾癌
Cancer Genet Cytogenet. 1982 Nov;7(3):271-5. doi: 10.1016/0165-4608(82)90074-7.
3
Familial renal cell carcinoma with a 3;11 chromosome translocation limited to tumor cells.家族性肾细胞癌,伴有限于肿瘤细胞的3号与11号染色体易位。
Science. 1982 Sep 3;217(4563):939-41. doi: 10.1126/science.7112106.
4
Diagnosis and management of asymptomatic renal cell carcinomas in von Hippel-Lindau syndrome.冯·希佩尔-林道综合征中无症状肾细胞癌的诊断与管理
Urology. 1983 Feb;21(2):146-50. doi: 10.1016/0090-4295(83)90010-9.
5
Involvement of band 3p14 in t(3;8) hereditary renal carcinoma.3p14区域在t(3;8)遗传性肾癌中的作用。
Cancer Genet Cytogenet. 1984 Apr;11(4):479-81. doi: 10.1016/0165-4608(84)90028-1.
6
Mutation and cancer: statistical study of retinoblastoma.突变与癌症:视网膜母细胞瘤的统计学研究
Proc Natl Acad Sci U S A. 1971 Apr;68(4):820-3. doi: 10.1073/pnas.68.4.820.
7
Mutation and cancer: a model for Wilms' tumor of the kidney.突变与癌症:肾母细胞瘤模型
J Natl Cancer Inst. 1972 Feb;48(2):313-24.
8
Mutation and cancer: neuroblastoma and pheochromocytoma.突变与癌症:神经母细胞瘤和嗜铬细胞瘤
Am J Hum Genet. 1972 Sep;24(5):514-32.
9
Cytogenetic studies of tumor tissue from patients with nonfamilial renal cell carcinoma.非家族性肾细胞癌患者肿瘤组织的细胞遗传学研究。
Cancer Res. 1986 Apr;46(4 Pt 2):2139-47.
10
Cerebellar haemangioblastoma and von Hippel-Lindau disease.小脑成血管细胞瘤与冯·希佩尔-林道病
Brain. 1986 Dec;109 ( Pt 6):1297-310. doi: 10.1093/brain/109.6.1297.